Shakila Thangaratinam
From Wikipedia, the free encyclopedia
University of Birmingham
Queen Mary University of London
Shakila Thangaratinam | |
|---|---|
 | |
| Alma mater | University of Birmingham |
| Scientific career | |
| Institutions | University of Liverpool University of Birmingham Queen Mary University of London |
| Thesis | Health technology assessment in maternal and perinatal medicine : delphi survey of practice, systematic reviews of evidence and meta analyses (2011) |
Shakila Thangaratinam is a British physician who is Professor of Women's Health at the University of Liverpool and a consultant obstetrician at Liverpool Women's University Hospital. She is executive dean of the Institute of Life Course and Medical Sciences, at the University of Liverpool. She is the vice president (International) of the Academy of Medical Sciences in the UK. She is an NIHR senior investigator. Her research has shaped global guidelines on COVID-19 in gestational diabetes, pre-eclampsia, pulse oximetry and epilepsy.
Thangaratinam completed her PhD at the University of Birmingham.[1] She trained there as a clinical lecturer in women's health.[2] She obtained her MRCOG from the Royal College of Obstetricians and Gynaecologists in 2003, and completed her clinical training in 2011.[citation needed]
